Axsome pushes back generic entry for narcolepsy drug until 2040
Axsome Therapeutics has successfully delayed generic competition for its narcolepsy drug Sunosi until 2040. The company announced on Wednesday that it has reached a settlement with the last applicant looking to ...
June 3, 2026 01:37 PM EDT PharmaLaw Axsome pushes back generic entry for narcolepsy drug until 2040 Nicole DeFeudis Senior Reporter Axsome Therapeutics has successfully delayed generic competition for its narcolepsy drug Sunosi until 2040. The company announced on Wednesday that it … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that